Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Silvio Inzucchi MD

Richard Pratley MD

Deborah Wexler MD, MSc

See All Experts

Published in Diabetes

Journal Scan / Research · July 21, 2023

Effects of Empagliflozin on Measured Glomerular Filtration Rate and Estimated Extracellular and Plasma Volumes in Patients With Type 2 Diabetes

Diabetes, Obesity & Metabolism

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Carolina Gonzalez-Lopez MD

Diabetes, Obesity & Metabolism

The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

Diabetes Obes Metab 2023 Jul 03;[EPub Ahead of Print], M Jürgens, M Schou, P Hasbak, A Kjaer, E Wolsk, B Zerahn, NH Brandt-Jacobsen, P Gaede, P Rossing, J Faber, SE Inzucchi, F Gustafsson, C Kistorp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Empagliflozin on Measured Glomerular Filtration Rate and Estimated Extracellular and Plasma Volumes in Patients With Type 2 Diabetes

Additional Info

The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

Further Reading

Deviations in HbA1c in Relation to Mean Glucose Levels and Time in Range Among Individuals With Type 1 Diabetes

Liver Fat Accumulation Is Associated With Increased Insulin Secretion Independent of Total, Visceral, and Pancreatic Fat

Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes

Heterogeneity of Glycaemic Phenotypes in Type 1 Diabetes

Identification and Validation of Gestational Diabetes Subgroups by Data-Driven Cluster Analysis

Use of Semaglutide for the Primary Prevention of Diabetic Kidney Disease in People With Type 2 Diabetes

Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia in Adults With Type 1 or Insulin-Treated Type 2 Diabetes Using Hypo-METRICS App

Accuracy of Continuous Glucose Monitoring in the Hospital Setting

Comparison of Renal Prognosis Between DPP-4 Inhibitor Users and Non-Users

Efficacy and Safety of Ultra–Rapid Acting vs Rapid-Acting Insulin Analogs in People With Type 1 or Type 2 Diabetes

Effect of Bariatric Surgery on Diabetes-Related Foot Complications in Patients With Type 2 Diabetes

Recently Updated